PapersPMID:32349742
The effect of aged garlic extract on the atherosclerotic process - a randomized double-blind placebo-controlled trial.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“There were no significant differences in the lipid profile, BMI or CRP between the AGE and the placebo groups.”
- Study
- RCT
- Duration
- 12 months
- Interests
- Industry funded
- Dose studied
- 2400 mg aged garlic extract daily (two 600 mg capsules twice daily), 12 months
- Population
- Asymptomatic adults aged 40 to 75 with Framingham risk score 10 or more and a positive coronary artery calcium score, most on antihypertensive or lipid-lowering medication; whole randomised population at 12 months
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- asymptomatic patients aged 40 to 75 years with a Framingham risk score of at least 10 and a positive coronary artery calcification score, Lund, Sweden
- Participants
- 104
- Comparator
- placebo
- Duration
- 365 days
- Endpoints measured
- 31